ASCO: GLP-1 Receptor Agonist Initiation Cuts Metastatic Progression Across Cancer Types

MONDAY, June 1, 2026 -- Across multiple solid tumors, glucagon-like peptide 1 receptor agonist (GLP-1 RA) initiation after cancer diagnosis is associated with reduced metastatic progression, according to a study presented at the annual meeting of...